Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety

Imtiaz Salim1, Jassim Al Suwaidi, Wissam Ghadban

  • 1Hamad Medical Corp., Doha, Qatar.

Insights

Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) face increased stroke risk. Warfarin anticoagulation is key for stroke prevention in CKD patients, but newer agents need further study.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) have a higher stroke incidence.
  • AF prevalence has increased in CKD patients over the past two decades.
  • Warfarin's safety and efficacy in severe CKD for AF stroke prevention remain under-documented.

Purpose of the Study:

  • To review the risks and benefits of long-term anticoagulation in AF patients with CKD.
  • To explore the role of novel anticoagulant agents in this patient population.

Main Methods:

  • A Medline literature search was conducted from 1980 to 2012.
  • Keywords included 'chronic kidney disease,' 'atrial fibrillation,' 'hemodialysis,' 'warfarin,' 'anticoagulation,' and 'new oral anticoagulants.'

Main Results:

  • Long-term warfarin anticoagulation with monitoring is considered essential for stroke prevention in CKD patients.
  • Evidence on newer agents in this population is limited.

Conclusions:

  • Warfarin is the current cornerstone for stroke prevention in CKD patients with AF.
  • Further research is needed to evaluate newer anticoagulants for safety and efficacy in this high-risk group to reduce stroke incidence.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...